Skip to main content
Equibles

APMC · AmperCap Acquisition Co

Track APMC — free

Use APMC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research APMC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$9.97 +0.01 (+0.05%) At close · Sep 11
Rebalance outlook locked
Going-concern doubt — cleared Aug 13, 2026

The latest filing states the doubt was alleviated.

“Following the closing of the Initial Public Offering, the Private Placement and the Over-Allotment Option, the Company has capital in excess of the funds deposited in the Trust Account and/or used to fund offering expenses that will be available to the Company for general working capital purposes. Accordingly, management has since re-evaluated the Company's liquidity and financial condition and determined that sufficient capital exists to sustain operations one year from the date the unaudited condensed financial statements was issued and therefore substantial doubt has been alleviated.”
View the 10-Q filed Aug 13, 2026
Market Cap
$198.79M
Shares
19.96M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$9.96 Open$9.97 Day$9.96–9.97 Available close range$9.89–9.98 Avg vol 30d63K Short int8K · 0.0% float · 1.0d Short vol0% DataJun 2026–Sep 2026 Filing10-Q · Aug 13

The closing range uses available history since Jun 29, 2026; less than a full year is stored.

Up next

Latest filing: 10-Q
filed Aug 13, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$796,296
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
0.0%
Latest settlement · 1.0 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Buy Momentum Limited Sentiment Neutral Fundamentals Limited Quant / Vol Very Low
Market backdrop VIX 15.8 · calm Equity put/call 0.58
Technical
price trend
Buy
50 / 200-day cross No cross
RSI (14) 57
neutral
MACD trend Positive
52-week position 78%
mid-range
Momentum
relative strength
Limited
Not enough data for a confident read.
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Accumulating
+53 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.04% of float · ▲ +4764.7% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
53 holders — 13F breadth
Squeeze score 37
low risk · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very Low
Volatility 2%
annualized · 1-yr
Max drawdown 0%
past year
ATR 0.2%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy
0 · 3 · 1
50 / 200-day cross
No cross Neutral
RSI (14)
57 Neutral
MACD trend
Positive Bullish
52-week position
78% Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Accumulating
+53 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.04% of float · ▲ +4764.7% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
53 holders — 13F breadth
Price context
position in its available closing range
Range low $10 Now $10 · 78% Range high $10

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Shell Companies — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
APMC
AmperCap Acquisition Co
this stock
$198.79M — — — 0.0%
CLUS
Cluster Group Holdings Ltd Co
 $8.00B — — — —
CCXI
Churchill Capital Corp XI
 $686.22M — — — 6.7%
DMII
Drugs Made In America Acquisition II Corp.
 $647.37M +2.7% — — 0.2%
EVAC
EQV Ventures Acquisition Corp. II
 $602.01M +2.7% — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
53
% held
88.6%
Net QoQ
+17.7M sh
Top holder
Magnetar Financial LLC
Held Float
View
Held by Funds
Fund positions
4
View
Short & Settlement
Short Interest Rising
Shares short
7.6K
Days to cover
1.0d
Change
+7.4K sh
View
Short Volume
Short vol %
0%
As of
Sep 10, 2026
Short Total
View
Fails to Deliver
FTD shares
5.3K
Value
$52.5K
As of
Jun 30, 2026
View
Off-Exchange
Off-exchange %
84.6%
Week of
Aug 3, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
10-Q
Filed
Aug 13, 2026
This year
6
View

Performance

5D 20D 120D MTD YTD
APMC -0.2% +0.5% — -0.2% —
SPY -1.0% -1.9% +14.9% -1.2% +11.1%
vs SPY +0.8% +2.4% — +1.0% —
Key facts CIK 2101393 CUSIP G0344N107 13F (30d) 34 filings 34 filers